Genelux (GNLX) Change in Taxes (2023 - 2026)
Genelux's (GNLX) quarterly Change in Taxes came in at -$580000.0 in Q1 2026, down 70.59% year-on-year from -$2.0 million in Q1 2025, and down 188.55% quarter-over-quarter from $655000.0 in Q4 2025.
Genelux (GNLX) Change in Taxes (2023 - 2026) Analysis & Trends
Genelux's Change in Taxes history runs 4 years deep, the most recent figure standing at -$580000.0 for Q1 2026.
- On a quarterly basis, Change in Taxes fell 70.59% year-over-year to -$580000.0 in Q1 2026; TTM through Mar 2026 was $198000.0, a 87.34% decrease from a year earlier, with the FY2025 full-year figure at $438000.0, up 139.35% from the prior year.
- Change in Taxes retreated to -$580000.0 in Q1 2026 per GNLX's latest filing, from $655000.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $1.4 million in Q3 2023 and bottomed at -$580000.0 in Q1 2026.
- The 4-year median for Change in Taxes is $169500.0 (2024), against an average of $220250.0.
- Across the five-year window, Change in Taxes tumbled 88.07% in 2024 and soared 105.97% in 2025, its largest moves.
- Year by year, Change in Taxes stood at $1.4 million in 2023, then sank by 77.56% to $318000.0 in 2024, then surged by 105.97% to $655000.0 in 2025, then slumped by 188.55% to -$580000.0 in 2026.
- Per Business Quant, the three latest GNLX Change in Taxes figures stand at -$580000.0 (Q1 2026), $655000.0 (Q4 2025), and $170000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 469.68 Bn | 464.89 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.76 Bn | 115.51 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.40 Bn | 61.65 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | - |
| 10 | Genelux | 128.48 Mn | 128.48 Mn | - | -580,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -580,000.00 |
| Mar 31, 2026 | -580,000.00 |
| Dec 31, 2025 | 655,000.00 |
| Dec 31, 2025 | 655,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | -47,000.00 |
| Jun 30, 2025 | -47,000.00 |
| Mar 31, 2025 | -340,000.00 |
| Mar 31, 2025 | -340,000.00 |
| Dec 31, 2024 | 318,000.00 |
| Dec 31, 2024 | 318,000.00 |
| Sep 30, 2024 | 169,000.00 |
| Sep 30, 2024 | 169,000.00 |
| Sep 30, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.42 Mn |